Home/Investors/Sequoia Capital China

Sequoia Capital China

Biotech Investor · 45 portfolio companies

Portfolio
45
Focus Areas
26
Top Stage
phase-2

Portfolio Companies

CompanyValuation
Genocury Biotech
VivaVision Biotech
Allorion Therapeutics
Tenacia Biotechnology
Ocumension Therapeutics
Lyvgen Pharma
Hua Medicine
Escugen
Full-Life Technologies
ChemPartner
Drug Farm
De Novo Pharmatech
Convalife Pharmaceuticals
MabPlex
Thousand Oaks Biopharmaceuticals
Biomics Biopharma
Vazyme
Vazyme
Triastek
Eaglenos Sciences
Quaero Life Science
AccuPulse
Innorna
Yirui Pharma
Venus MedTech
Qihan Biotech
Lynk Pharmaceuticals
HighField Biopharmaceuticals
Bota Bio
Xiangxue Life Sciences
MingMed Biotechnology
Excelmab
Fapon Biotech
Fapon Biopharma
Sintaho Pharmaceutical
TransGen Biotech
Surgerii Robotics
MegaRobo
GrandOmics Biosciences
Coyote Bioscience
BroadenBio
Ascentawits Pharmaceuticals
Annoroad Genomics
Tianhu Technology
CSR Biotech